Next article

The OECD holds a roundtable on competition and regulation issues in the pharmaceutical industry

Executive summary, by the Secretariat In the light of the written submissions, the background note and the oral discussion, the following points emerge: (1) The pharmaceutical sector is a high-technology and knowledge-intensive industry. The industry has a two-tier structure. The largest firms account for the majority of the R&D investment in the industry and hold the majority of patents. A large number of smaller firms manufacture off-patent products or under license to a patent-holder. The pharmaceutical industry is heavily regulated. Few aspects of the industry are unaffected by regulatory controls. The pharmaceutical sector produces and distributes chemicals with therapeutic value. Pharmaceuticals are an important input into health services more generally. Pharmaceutical

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • OECD - Competition Division (Paris)

Quotation

OECD, The OECD holds a roundtable on competition and regulation issues in the pharmaceutical industry, 1 June 2000, e-Competitions June 2000, Art. N° 85744

Visites 88

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues